97 related articles for article (PubMed ID: 18822131)
1. RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma.
Tezval H; Merseburger AS; Matuschek I; Machtens S; Kuczyk MA; Serth J
BMC Urol; 2008 Sep; 8():12. PubMed ID: 18822131
[TBL] [Abstract][Full Text] [Related]
2. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
[TBL] [Abstract][Full Text] [Related]
3. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
[TBL] [Abstract][Full Text] [Related]
4. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.
Costa VL; Henrique R; Ribeiro FR; Pinto M; Oliveira J; Lobo F; Teixeira MR; Jerónimo C
BMC Cancer; 2007 Jul; 7():133. PubMed ID: 17645803
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer.
Kee SK; Lee JY; Kim MJ; Lee SM; Jung YW; Kim YJ; Park JY; Bae HI; Hong HS; Yun YK; Kim SG; Kim DS
Mol Cells; 2007 Dec; 24(3):364-71. PubMed ID: 18182852
[TBL] [Abstract][Full Text] [Related]
6. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue.
Peters I; Vaske B; Albrecht K; Kuczyk MA; Jonas U; Serth J
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2526-32. PubMed ID: 18086755
[TBL] [Abstract][Full Text] [Related]
7. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
[TBL] [Abstract][Full Text] [Related]
8. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
Li JF; Chu YW; Wang GM; Zhu TY; Rong RM; Hou J; Xu M
BJU Int; 2009 Feb; 103(3):399-405. PubMed ID: 19021626
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.
Avigad S; Shukla S; Naumov I; Cohen IJ; Ash S; Meller I; Kollender Y; Issakov J; Yaniv I
Pediatr Blood Cancer; 2009 Dec; 53(6):1023-8. PubMed ID: 19637319
[TBL] [Abstract][Full Text] [Related]
12. Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma.
Campbell L; Nuttall R; Griffiths D; Gumbleton M
Cancer; 2009 Aug; 115(15):3457-67. PubMed ID: 19526593
[TBL] [Abstract][Full Text] [Related]
13. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma.
Gacci M; Serni S; Lapini A; Vittori G; Alessandrini M; Nesi G; Palli D; Carini M
J Urol; 2009 Feb; 181(2):843-8. PubMed ID: 19095263
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis.
Mhawech-Fauceglia P; Herrmann FR; Andrews C; South S; Beck A; Lele S; Odunsi K
Eur J Surg Oncol; 2009 Jul; 35(7):763-7. PubMed ID: 19081223
[TBL] [Abstract][Full Text] [Related]
15. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A expression inhibits cell growth and enhances cell chemosensitivity to mitomycin in BEL-7402 hepatocellular carcinoma cells.
Guan HG; Xue WJ; Qian HX; Zhou XJ; Qin L; Lan J
Chin Med J (Engl); 2009 Jun; 122(11):1328-32. PubMed ID: 19567146
[TBL] [Abstract][Full Text] [Related]
17. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
19. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
[TBL] [Abstract][Full Text] [Related]
20. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
